Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Scientists use CRISPR to edit immune cell DNA

03 August 2015

By Lubna Ahmed

Appeared in BioNews 813

Researchers have successfully used the technique CRISPR/Cas 9 to cut and paste DNA into T-cells of the immune system.

The method could lead to new ways to treat cancer, type 1 diabetes and viral infections as well as facilitating research into T-cell function.

'Genome editing in human T-cells has been a notable challenge for the field,' said lead author Dr Alexander Marson from the University of California, San Francisco.

'We have now been able to cut as well as paste pieces of the genome into human T-cells – for the first time to our knowledge,' he added.

In the experiment, the team were able to disable a protein found on T-cells, called CXCR4, resulting in those cells no longer being prone to invasion by the HIV virus.

They also used CRISPR/Cas9 to shut down a protein found on T-cells, known as PD-1, which has been shown to up-regulate the body's attack on invasive cancer cells when blocked. The researchers hope that, in this way, T-cells could be manipulated to control cancer or possibly eliminate a tumour entirely.

CRISPR/Cas9 involves the identification of specific areas on the DNA. With the use of an enzyme, Cas9, the strands are cut and replaced with alternative copies of the DNA sequence, usually using a modified virus as a vector. However, to date, scientists have not been able to use the technique to modify specific sequences of DNA in T-cells with sufficient success.

In this study, which is published in PNAS, the researchers modified the technique by attaching guide RNA to the Cas9 enzyme in the lab. Then, instead of using a viral vector, they used a technique called electroporation, which involves subjecting the cells to an electric field that temporarily makes their membranes permeable, allowing the CRISPR/Cas9 molecule to enter.

Using cell-surface markers, the researchers were then able to sift out the 20 percent of cells that had successfully undergone gene editing.

'It has been really challenging to get CRISPR to work in T-cells. This, in our hands, allows us to achieve a new level of efficiency for cutting and repair,' said Dr Marson, who worked alongside CRISPR pioneer Jennifer Doudna on the study.

Dr Marson said that there was still work to be done to make sure that the technique correctly targets DNA before being used in humans.

'I think CRISPR-edited T-cells will eventually go into patients, and it would be wrong not to think about the steps we need to take to get there safely and effectively,' he commented.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

11 April 2016 - by James Brooks 
Scientists testing whether the CRISPR genome-editing technique could effectively kill HIV in infected cells have found that, while the approach works in most cases, it can also cement the virus's presence...
04 April 2016 - by Dr Lanay Griessner 
Scientists have used the CRISPR genome-editing technique to remove HIV from the DNA of infected T cells and prevent reinfection...
26 October 2015 - by Paul Waldron 
Scientists have used 'genome surgery' to change the way DNA is packed inside human cells...
26 October 2015 - by Isobel Steer 
Scientists in China have used the gene-editing technique CRISPR/Cas9 to create dogs with increased muscle mass...
05 October 2015 - by Meghna Kataria 
Scientists have identified a new version of the gene-editing technique CRISPR, which could enable greater precision in the editing of genomes, while making its use simpler and more flexible...

18 May 2015 - by Ari Haque 
Patents for the gene-editing technology, CRISPR/Cas9, are the subject of a dispute between scientists at University of California, Berkeley and the Broad Institute of MIT and Harvard....
11 May 2015 - by Dr Indrayani Ghangrekar & Ayala Ochert 
Molecular biologists have used gene-editing technology to identify promising targets for anti-cancer drugs...
05 May 2015 - by Dr James Heather 
US researchers have used the CRISPR/Cas9 system to target hepatitis C infection in human cells...
28 July 2014 - by Dr James Heather 
Research has shown that it may be possible to 'cut' the viral DNA out of cells infected by HIV using genetic editing techniques, removing its ability to replicate...
11 November 2013 - by Dr Anna Cauldwell 
A molecular technique that enables any part of the human genome to be altered with extreme precision has been hailed by scientists as a breakthrough in genetics...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation